Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Famar","sponsor":"Medicom Healthcare","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"FAMAR and Medicom Healthcare Announce The Acquisition By Medicom Of The Pharmaceutical Dossier Of BIMATOPROST","therapeuticArea":"Ophthalmology","highestDevelopmentStatus":"Approved","country":"GREECE","productType":"Small molecule","productStatus":"Approved","date":"February 2021","url1":"","url2":"","graph1":"Ophthalmology","graph2":"Approved"},{"orgOrder":0,"company":"Famar","sponsor":"Active Biotech","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Active Biotech Enters into a Manufacturing Agreement with Famar Health Care Services for New Formulation of Laquinimod","therapeuticArea":"Ophthalmology","highestDevelopmentStatus":"Phase I","country":"GREECE","productType":"Small molecule","productStatus":"Approved","date":"February 2021","url1":"","url2":"","graph1":"Ophthalmology","graph2":"Phase I"},{"orgOrder":0,"company":"Famar","sponsor":"LaviPharm","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"New Collaboration Between FAMAR and Lavipharm: Joining Forces in the Production of Pharmaceutical Products","therapeuticArea":"Immunology","highestDevelopmentStatus":"Approved","country":"GREECE","productType":"Small molecule","productStatus":"Approved","date":"January 2024","url1":"","url2":"","graph1":"Immunology","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals by Famar

    Menu

    Famar

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Famar

              Contact Supplier
              • Deals
              Virtual BoothFAMAR CDMO- From early development to commercial manufacturing.
              Contact Supplier Contact Supplier
              Flag Greece
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              New Collaboration Between FAMAR and Lavipharm: Joining Forces in the Production of Pharmaceutical Products

              Details:

              Under the collaboration, FAMAR will undertake the production of two pharmaceutical products recently added to Lavipharm’s portfolio of analgesic pharmaceutical products, Lonarid N (paracetamol) and Lonalgal (caffeine Anhydrous).

              Lead Product(s): Paracetamol,Caffeine

              Therapeutic Area: Immunology Product Name: Lonarid N

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: LaviPharm

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration January 23, 2024

              Famar

              15th Global DDF Summit

              Attending

              envelop Contact Supplier

              Famar

              Contact Supplier
              • Deals
              Virtual BoothFAMAR CDMO- From early development to commercial manufacturing.
              Contact Supplier Contact Supplier
              Flag Greece
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              FAMAR and Medicom Healthcare Announce The Acquisition By Medicom Of The Pharmaceutical Dossier Of BIMATOPROST

              Details:

              Under the agreement, Medicom has acquired the ownership of the pharmaceutical dossier of Zimed (bimatoprost), a preservative free eye drop solution, which is already registered in the UK and 5 EU countries with plans to commercialise the asset globally.

              Lead Product(s): Bimatoprost

              Therapeutic Area: Ophthalmology Product Name: Zimed

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Medicom Healthcare

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Acquisition February 09, 2021

              Famar

              15th Global DDF Summit

              Attending

              envelop Contact Supplier

              Famar

              Contact Supplier
              • Deals
              Virtual BoothFAMAR CDMO- From early development to commercial manufacturing.
              Contact Supplier Contact Supplier
              Flag Greece
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Active Biotech Enters into a Manufacturing Agreement with Famar Health Care Services for New Formulation of Laquinimod

              Details:

              Through the agreement, Active Biotech will get the material for the clinical development of the eye-drop formulation of ABR-215062 (laquinimod), which is used for the treatment of non-infectious non-anterior uveitis.

              Lead Product(s): Laquinimod

              Therapeutic Area: Ophthalmology Product Name: ABR-215062

              Highest Development Status: Phase I Product Type: Small molecule

              Partner/Sponsor/Collaborator: Active Biotech

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement February 04, 2021

              Famar

              15th Global DDF Summit

              Attending

              envelop Contact Supplier

              Famar
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY